type in your search and press enter
New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
You May Also Like
Summit Obtains Innovative Antibiotic Discovery and Development Platform Through Acquisition of Discuva Ltd
Positions Summit as a Leader in Research & Development of New Classes of AntibioticsEnhances ...
Vical to Present VL-2397 Data at the June ASM Microbe 2017 Meeting
SAN DIEGO, May 23, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that ...
